kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports KRAS G12V mutation-selective requirement for
KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports What should we know about the 'undruggable' target KRAS? MedChemExpress Uncovering new therapeutic targets for a common KRAS mutation behind cancer The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy PMC KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8




